Get the Stockscreener App
314.91
0.86%
2.5901
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $314.91, with a volume of 551.93K.
It is up +0.86% in the last 24 hours and down -7.81% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
See More
Previous Close:
$312.32
Open:
$312.24
24h Volume:
551.93K
Relative Volume:
0.42
Market Cap:
$87.35B
Revenue:
$229.75B
Net Income/Loss:
$3.04B
P/E Ratio:
17.76
EPS:
17.7276
Net Cash Flow:
$5.18B
1W Performance:
+2.20%
1M Performance:
-7.81%
6M Performance:
-7.76%
1Y Performance:
+1.40%
1-Day Range:
$311.26
$316.23
1-Week Range:
$306.66
$342.39
52-Week Range:
$253.95
$370.82
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Piper Sandler Reiterates Overweight Rating for The Cigna Group (NYSE:CI) - MarketBeat
Barclays Boosts The Cigna Group (NYSE:CI) Price Target to $420.00 - MarketBeat
Asset Management One Co. Ltd. Has $42.38 Million Position in The Cigna Group (NYSE:CI) - MarketBeat
Cigna Saudi: Enhancing Healthcare Delivery in the Kingdom - Insurance Edge
The Cigna Group (NYSE:CI) Cut to Buy at StockNews.com - MarketBeat
Cigna Scores $7.3M Verdict Against Fla. Drug Testing Labs - Law360
Piper Sandler raises CIGNA target to $394 on EPS growth - Investing.com
Piper Sandler raises CIGNA target to $394 on EPS growth By Investing.com - Investing.com UK
CIGNA (CI) PT Raised to $394 at Piper Sandler - StreetInsider.com
Deutsche Bank Aktiengesellschaft Lowers The Cigna Group (NYSE:CI) Price Target to $394.00 - MarketBeat
Price Over Earnings Overview: Cigna - Benzinga
Robeco Institutional Asset Management B.V. Cuts Stake in The Cigna Group (NYSE:CI) - MarketBeat
Cigna Healthcare signs agreement with Infirmary Health to expand Medicare access - Yahoo! Voices
Cigna Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana, Cigna report Q3 earnings amid lawsuits and rumors - Healthcare Brew
Stephens Reiterates "Overweight" Rating for The Cigna Group (NYSE:CI) - MarketBeat
Cigna shares target cut to $406 from $422, maintains buy rating - Investing.com
Royal Bank of Canada Cuts The Cigna Group (NYSE:CI) Price Target to $377.00 - MarketBeat
The Cigna Group (NYSE:CI) Issues Quarterly Earnings Results - MarketBeat
New York State Common Retirement Fund Cuts Stock Position in The Cigna Group (NYSE:CI) - MarketBeat
Cigna's 2025 health plan prices based on 'higher than normal' cost increases - BenefitsPro
The Cigna Group reports 30% revenue growth in Q3 - Insurance Business America
The Cigna Group posts 30% revenue growth - Insurance Business
Is The Cigna Group's (NYSE:CI) Stock Price Struggling As A Result Of Its Mixed Financials? - Simply Wall St
Cigna Healthcare, Infirmary Health Reach Medicare Advantage Agreement - PR Newswire
The Cigna Group Reports Strong Third Quarter 2024 Results, Reaffirms 2024 Adjusted EPS Outlook - StreetInsider.com
CIGNA (CI) PT Lowered to $406 at Jefferies - StreetInsider.com
The Cigna Group (CI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
The Cigna Group (CI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Cigna reports $739M profit despite $1B investment loss - Business Insurance
Decoding The Cigna Group (CI): A Strategic SWOT Insight - Yahoo Finance
Cigna Reports Strong Q3 2024 Results with Revenue Surge - TipRanks
Amid Unsettled Insurer Market, Cigna Posts Positive Q3 Results - Healthcare Innovation
Cigna, Hartford HealthCare reach new agreement - Hartford Business Journal
Cigna (CI) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call: Cigna Group reported a revenue quarter of $63.7 billion - Investing.com India
The Cigna Group Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Cigna Q3 Earnings Beat On Client Wins & Specialty Business Strength - Barchart
Cigna Earnings: Solid Results and 2024 Outlook Despite Rising Medical Utilization - Morningstar
Cigna CEO tamps down on Humana deal speculation - Healthcare Dive
The Cigna Group (NYSE:CI) Shares Gap UpHere's Why - MarketBeat
Cigna forecasts 2025 profit growth of at least 10% after quarterly beat By Reuters - Investing.com
Cigna Group (CI) Q3 2024 Earnings Call Transcript - The Motley Fool
Cigna forecasts 2025 profit growth of at least 10% after quarterly beat - MSN
The Cigna Group (NYSE:CI) Releases FY24 Earnings Guidance - MarketBeat
Cigna Focuses on Commercial Insurance and Biopharmaceutical Benefits - Morningstar
Physician Associate Foundation Receives Grant from The Cigna Group Foundation to Address Youth Mental Health Crisis - AAPA
Cigna reports $700M 3Q profit despite $1B loss from VillageMD investment - Hartford Business Journal
Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients - Benzinga
Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength - Yahoo Finance
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):